About "Drug Development Clearly Explained" | Dr Gray has done a masterful job of explaining each stage of the drug development process. This book will become an invaluable resource for anyone associated with drug development and commercialization. It is crucial for early stage pharma and biotech companies to understand fully all the aspects of the drug development process and to maintain a commercial focus throughout the development process. It is refreshing to see a comprehensive drug development resource that starts with a market focus and advocates the development of target product profiles to help guide drug development plans. Dr Gray's book is easy to read and will help both business managers and researchers alike fill knowledge gaps in the drug development process and facilitate cross functional collaborations within drug development project teams. As a consultant working with early stage specialty pharma companies, Dr Gray?s book provides a comprehensive overview that I can reference when working with clients and use as a guide throughout the business planning process. - Thomas Marten, President, Pharmacision LLC, Michigan USA
About the Course | Dear Julian, On behalf of Evolva's team I wanted to drop you a line to thank you for the very interesting and informative Alladex one day course. Your presentation of the topic was well in tune with the needs of our scientific, program manager and business development team. As I told you during the course, Evolva, as a Drug Discovery and Development company has decided very early on to put an emphasis on such education to open up the employees to the realities and constraints linked to regulatory affairs in drug development. Very often the arcane of regulatory affairs are overlooked in companies, resulting in poor integration of the whole process in early stage or misunderstandings between the cross functional teams leading the compounds forward. The methodology you have chosen, where you alternate hard core presentation and small movies of interviews of CRO, professionals in the field and regulatory affairs specialists resulted in a very lively and enjoyable course for a topic which is sometimes quite dry. Our team has walked away from the course with a broader understanding of the whole process to get a drug on the market. Thanks also for the e-Book covering the course subject and the numerous links and guidance it offers. I would wholeheartedly recommend your course to professionals, being venture capitalists, business development personnel, program managers or scientists involved in drug discovery and development. Cheers, Pascal Longchamp, VP Business Development, Evolva SA, Basel Switzerland www.evolva.com"
About "Drug Development Clearly Explained" | This superb account of the subject succeeds in extracting the essentials while being of sufficient depth to make it suitable for a range of readers from science and business backgrounds, from beginners to those with prior knowledge in one area. The linkage to regulatory guidelines is of particular value, making this a unique learning tool. The clarity of the text reflects the teaching style of Dr Gray on the European Course of Pharmaceutical Medicine which has been highly valued over many years. Professor Fritz Buhler, MD, Professor of Pharmaceutical Medicine and Pathophysiology, University of Basel, former Head of Worldwide Clinical R&D at Roche, Basel, Switzerland |
[1]